Marchex Yönetim

Yönetim kriter kontrolleri 1/4

Marchex CEO'su Edwin Miller, Feb2023 tarihinde atandı, in görev süresi 1.75 yıldır. in toplam yıllık tazminatı $ 1.50M olup, şirket hissesi ve opsiyonları dahil olmak üzere 25.8% maaş ve 74.2% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.77% ine doğrudan sahiptir ve bu hisseler $ 552.72K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 1.6 yıl ve 7.3 yıldır.

Anahtar bilgiler

Edwin Miller

İcra Kurulu Başkanı

US$1.5m

Toplam tazminat

CEO maaş yüzdesi	25.8%
CEO görev süresi	1.8yrs
CEO sahipliği	0.8%
Yönetim ortalama görev süresi	1.6yrs
Yönetim Kurulu ortalama görev süresi	7.3yrs

Son yönetim güncellemeleri

Recent updates

Marchex, Inc. (NASDAQ:MCHX) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Aug 05

Will Marchex (NASDAQ:MCHX) Spend Its Cash Wisely?

Mar 01

Is Marchex (NASDAQ:MCHX) In A Good Position To Deliver On Growth Plans?

Oct 19

What You Can Learn From Marchex, Inc.'s (NASDAQ:MCHX) P/SAfter Its 26% Share Price Crash

Sep 14

CEO Tazminat Analizi

Edwin Miller'un ücretlendirmesi Marchex'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	-US$4m
Jun 30 2024	n/a	n/a	-US$5m
Mar 31 2024	n/a	n/a	-US$7m
Dec 31 2023	US$1m	US$386k	-US$10m

Tazminat ve Piyasa: Edwin 'nin toplam tazminatı ($USD 1.50M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 653.78K ).

Tazminat ve Kazançlar: Edwin şirketinin tazminatını şirket performansıyla karşılaştırmak için yeterli veri yok.

CEO

Edwin Miller (54 yo)

1.8yrs

Görev süresi

US$1,499,136

Tazminat

Mr. Edwin A. Miller serves as Chief Executive Officer of Marchex, Inc. since February 03, 2023. He founded 9Lenses LLC in 2010 and serves as its Chief Executive Officer. He served as President, Chief Execu...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Russell Horowitz	Executive Chairman	7.3yrs	US$537.43k	13.14% $ 9.4m
Edwin Miller	Chief Executive Officer	1.8yrs	US$1.50m	0.77% $ 552.7k
Michael Arends	Vice Chairman & Principal Accounting Officer	1.8yrs	US$530.62k	3.35% $ 2.4m
Holly Aglio	Chief Financial Officer	1.1yrs	US$630.75k	0% $ 0
Troy Hartless	Chief Revenue Officer	1.6yrs	US$978.50k	0% $ 0
Trevor Caldwell	Senior Vice President of Investor Relations & Strategic Initiatives	no data	Veri yok	Veri yok
Lyall Vanatta	Vice President of Marketing	less than a year	Veri yok	Veri yok
Julie Warner	Vice President of People Services	no data	Veri yok	Veri yok
Matt Muilenburg	Chief Market Development Officer	no data	Veri yok	Veri yok
Todd Wilson	Senior VP of Product	no data	Veri yok	Veri yok
Cullen Davidson	Senior Vice President of Engineering	less than a year	Veri yok	Veri yok
Francis Feeney	Chief Corporate & Strategic Affairs Officer and Company Secretary	no data	Veri yok	Veri yok

1.6yrs

Ortalama Görev Süresi

53.5yo

Ortalama Yaş

Deneyimli Yönetim: MCHX 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.6 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Russell Horowitz	Executive Chairman	7.3yrs	US$537.43k	13.14% $ 9.4m
Michael Arends	Vice Chairman & Principal Accounting Officer	1.8yrs	US$530.62k	3.35% $ 2.4m
Dennis Cline	Independent Director	21.5yrs	US$68.60k	0.27% $ 197.5k
M. Wisehart	Independent Director	16yrs	US$68.60k	0.75% $ 536.3k
Donald Cogsville	Independent Director	5.6yrs	US$68.60k	0.21% $ 151.3k

7.3yrs

Ortalama Görev Süresi

58yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: MCHX 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7.3 yıldır).

Marchex Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Chief Executive Officer recently bought US$183k worth of stock

Marchex, Inc., Annual General Meeting, Oct 30, 2024

Marchex, Inc., Annual General Meeting, Oct 30, 2024

Chief Executive Officer recently bought US$272k worth of stock

Marchex, Inc., Annual General Meeting, Sep 28, 2023

Marchex, Inc. Announces Executive Changes

Recent updates

Chief Executive Officer recently bought US$183k worth of stock

New major risk - Revenue and earnings growth

Marchex, Inc. Provides Earnings Guidance for the Fourth Quarter Ending December 31, 2024 and First Quarter and Full Year of 2025

Third quarter 2024 earnings: EPS misses analyst expectations

Marchex Announces Additional AI Solutions to Empower Businesses

Marchex, Inc. to Report Q3, 2024 Results on Oct 31, 2024

Marchex, Inc., Annual General Meeting, Oct 30, 2024

Marchex, Inc., Annual General Meeting, Oct 30, 2024

Consensus EPS estimates upgraded to US$0.085 loss

Second quarter 2024 earnings: EPS exceeds analyst expectations

Marchex, Inc. Provides Earnings Guidance for the Third Quarter Ending September 30, 2024

Marchex, Inc. (NASDAQ:MCHX) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Marchex, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Chief Executive Officer recently bought US$272k worth of stock

New minor risk - Shareholder dilution

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Marchex, Inc. Provides Revenue Guidance for the Second Quarter Ending June 30, 2024

Marchex, Inc. to Report Q1, 2024 Results on May 07, 2024

Marchex Launches Generative Ai-Powered Sentiment Suite Across Multiple Apis

Consensus EPS estimates upgraded to US$0.12 loss, revenue downgraded

Full year 2023 earnings: EPS exceeds analyst expectations

Marchex, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year of 2024

Marchex, Inc. to Report Q4, 2023 Results on Mar 14, 2024

Will Marchex (NASDAQ:MCHX) Spend Its Cash Wisely?

Third quarter 2023 earnings: EPS exceeds analyst expectations

Marchex, Inc. Provides Earnings Guidance for Fourth Quarter Ending December 31, 2023 and Fiscal Year 2024

New major risk - Revenue and earnings growth

Marchex, Inc. Launches Call Summary and Sentiment Suite Capabilities for Vertical Markets

Marchex, Inc. to Report Q3, 2023 Results on Nov 08, 2023

Is Marchex (NASDAQ:MCHX) In A Good Position To Deliver On Growth Plans?

What You Can Learn From Marchex, Inc.'s (NASDAQ:MCHX) P/SAfter Its 26% Share Price Crash

Marchex, Inc., Annual General Meeting, Sep 28, 2023

New major risk - Financial position

Second quarter 2023 earnings: EPS exceeds analyst expectations

Companies Like Marchex (NASDAQ:MCHX) Are In A Position To Invest In Growth

Consensus EPS estimates fall by 29%

First quarter 2023 earnings: EPS misses analyst expectations

Full year 2022 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 66%

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased by 7.1% to US$3.25

Marchex, Inc. to Report Q4, 2022 Results on Feb 28, 2023

Marchex, Inc. Announces Executive Changes

We're Not Very Worried About Marchex's (NASDAQ:MCHX) Cash Burn Rate

Insufficient new directors

Marchex, Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Marchex, Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Marchex, Inc. to Report Q3, 2022 Results on Nov 03, 2022

We're Hopeful That Marchex (NASDAQ:MCHX) Will Use Its Cash Wisely

Marchex, Inc., Annual General Meeting, Sep 29, 2022

Consensus forecasts updated

Second quarter 2022 earnings: EPS exceeds analyst expectations

Marchex, Inc. to Report Q2, 2022 Results on Aug 09, 2022

Insufficient new directors

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Marchex, Inc. Provides Earnings Guidance for the Second Quarter of 2022

Marchex, Inc. to Report Q1, 2022 Results on May 12, 2022

Insufficient new directors

Price target decreased to US$3.50

We're Hopeful That Marchex (NASDAQ:MCHX) Will Use Its Cash Wisely

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Marchex Inc. Launches Conversation Dna, Delivering Powerful Ai Signals Through Every Marchex Conversation Intelligence Product

Marchex, Inc. to Report Q4, 2021 Results on Mar 02, 2022

Price target decreased to US$4.00

Third quarter 2021 earnings released: EPS US$0.083 (vs US$0.078 loss in 3Q 2020)

Marchex: Hope Springs Eternal

Second quarter 2021 earnings released: US$0.008 loss per share (vs US$0.096 loss in 2Q 2020)

Does Marchex (NASDAQ:MCHX) Have A Healthy Balance Sheet?